Boston, MA 03/06/2014 (wallstreetpr) – Horizon Pharma Inc. (NASDAQ:HZNP) stock have been upgraded to a sell by TheStreet research firm citing massive improvements in some of its key operating sectors. The company stock could offer a good play for many investors as it currently commands a good a short term momentum as well as positive earnings estimate.
Horizon Pharma stock continue to show strengths with robust revenue growth as well as solid stock prices which have been growing over the recent past.
Highlights of the Hold rating
Horizon Pharma Inc. (NASDAQ:HZNP) revenue growth metric is quite high exceeding that of the industry average which stands at 2.8%. Revenues having grown by 302.1% over the past year alone, things could look brighter in the coming quarters. Growth in revenue has subsequently helped in boosting the company’s earnings per share
Horizon Pharma Inc. (NASDAQ:HZNP) stock have surged by 460% over the past year alone powered by strong earnings growth of 82.97%, it has also outpaced the S&P 500 index. Hold ratings by TheStreet indicates that one should not massively invest in the stock as things could change faster than anticipated. Horizon Pharma return on equity ratio is higher in the current quarter compared to the same quarter year ago. This is a clear sign of strength within the company.
Horizon Pharma Inc. (NASDAQ:HZNP) gross profit margin is currently high clocking in at 87.30% having increased massively over the past year alone. The company’s net profit margin is slightly an underperformer, as it is in line with the industry average of 20.94%. HZNP debt to equity ratio continues to be low at 0.65 but slightly higher compared to the industry average. This is a sign that the company’s management ought to do better in this case. Despite a low debt to equity ratio the company continues to command a quick ratio of 1.67 demonstrating strong liquidity margins.
Horizon Pharma Inc. (NASDAQ:HZNP) continues the rally in the market having surged by 2.69% in Wednesday trading session to close the day at highs of $13.34
